肿瘤患者代谢综合征及其组分异常的患病现况研究  

A cross-sectional study on metabolic syndrome and its abnormal components in cancer patients

作　　者：高鹰[1] 孙绍梅[1] 樊娜 魏玮 张卿[1] Gao Ying;Sun Shaomei;Fan Na;Wei Wei;Zhang Qing(Health Management Center,Tianjin Medical University General Hospital,Tianjin 300052,China;School of Public Health,Tianjin Medical University,Tianjin 300070,China)

机构地区：[1]天津医科大学总医院健康管理中心,300052 [2]天津医科大学公共卫生学院,300070

出　　处：《中华预防医学杂志》2021年第2期258-262,共5页Chinese Journal of Preventive Medicine

基　　金：国家自然科学基金(71804124)

摘　　要：2017年12月至2018年12月,在天津医科大学总医院健康管理中心定期健康体检的3 509名研究对象中,曾罹患肿瘤、罹患慢病和健康对照三组分别有399、1 555、1 555名。年龄为(55.87±11.98)岁,男性占31.38%。慢病组MS患病率(42.44%)高于曾罹患肿瘤组(34.59%)和健康对照组(18.65%)( P<0.001)。与健康对照组相比,曾罹患肿瘤组和慢病组MS患病风险 OR(95% CI)值分别为2.13(1.61~2.83)和2.85(2.23~3.66);曾罹患乳腺癌和甲状腺癌MS患病风险 OR(95% CI)值分别为3.56(2.04~6.21)和2.77(1.46~5.25)。From December 2017 to December 2018,3509 subjects who had regular physical examination in Health Management Center,Tianjin Medical University General Hospital were enrolled in our study,including 399 cancer patients,1555 chronic disease patients,and 1555 healthy control,respectively.The mean age was(55.87±11.98)years,and 31.38%were men.The prevalence of MS among chronic disease group(42.44%)was higher than that of cancer group(34.59%)and healthy control group(18.65%)(P<0.001).Compared with healthy control group,the OR(95%CI)values of MS risk in cancer group and chronic disease group were 2.13(1.61-2.83)and 2.85(2.23-3.66),respectively;the OR(95%CI)values of MS risk were 3.56(2.04-6.21)and 2.77(1.46-5.25)in breast cancer and thyroid cancer,respectively.

关 键 词：肿瘤 横断面研究 代谢综合征 

分 类 号：R589[医药卫生—内分泌] R73[医药卫生—内科学]